Skinbiotherapeutics Share Discussion Threads

[rafboy] 27/3/2018 08:45

I don’t think people realise how cheap this is. Once the human skin trials are complete it is very likely to be followed in short order by a commercial deal. This should all happen by year end. You will be paying 3 or 4 times the current share price then IMHO.

[elrico] 26/3/2018 17:10

hTTps://www.directorstalkinterviews.com/skinbiotherapeutics-interest-microbiome-huge/412748086

[bobalot] 26/3/2018 13:33

Nicola Davis a writer at The Guardian has just published an article ‘The human microbiome: why our microbes could be key to our health’ explains to readers the importance of microbes, how they interact with our body and why the microbiome has become such a hot topic for research.

SkinBioTherapeutics CEO Dr Catherine O’Neill commented on the article saying: “The level of interest in the microbiome is huge. People understand about the gut but now they’re beginning to see that the microbiome of other body systems is important also.”

SkinBioTherapeutics Plc (LON:SBTX) is targeting three specific skin healthcare sectors; cosmetics, infection control and eczema. In each of these areas Skin BioTherapeutics plans to exemplify its technology in human studies. The most advanced programme is focused on the application of the Skinbiotix® platform in managing sensitive skin in the cosmetics industry. The business strategy is to partner and outlicense its programmes at proof of concept. The Skin Care Market is area of high growth currently worth $100+bn. For more information visit:

To read the article click on the link provided:

[bobalot] 22/3/2018 10:11

with the share price at this level its a very good time to top up or enter the market as the Human Trials will start to loom large as we get closer to Q3.

[bobalot] 16/3/2018 19:09

Most of the gains made over the last few weeks have held up.

Lets see what next week brings; perhaps more buying pressure :-)

[elrico] 16/3/2018 16:24

It won't be breaking out today.

[bobalot] 16/3/2018 13:52

The share price is moving up on very small volume; perhaps some breaking news will be in the offering.

[elrico] 16/3/2018 10:43

Company CEO Cath O'Neill is to present at the 5th European Microbiome R&D and Business Collaboration Forum which will be held on March 21-22, 2018 in Rotterdam, the Netherlands. @lifesciences_GE #SBTX

[bobalot] 16/3/2018 09:20

When this breaks the 10p resistance then it's a blue sky rise to 11.3p; the next resistance level imo....happier days ahead.

[fredd] 16/3/2018 08:33

The 08.06 transaction of 50k at 0.0948 was a buy.

[parob] 16/3/2018 08:28

Chart looks ready to break out.

[bobalot] 16/3/2018 08:14

Good start this morning as the buying continues following on from The Paris Big Pharma presentation and partnering event where SkinBio presented its groundbreaking technology.

[rafboy] 15/3/2018 16:44

Thanks Bobalot

[bobalot] 15/3/2018 16:32

Here is the Share Mag mistake


An article published states that SBTX will enter trials at the end of next year:

Skin health life science company SkinBioTherapeutics (SBTX:AIM) should complete human trials next year, being part of the process to develop its cosmetic


But the trials are scheduled for this year in Q3, so your article needs to be corrected. Regards


Here is the one liner from Shares Mag:

Thank you for your email. I have forwarded this on to be corrected.

Kind regards,

Becca

[rafboy] 15/3/2018 16:28

Bobalot says he has contacted shares mag and the article is being corrected to show an end date of this year for human trials.

[shrewdmole] 15/3/2018 16:21

What?

I have bob a job on filter so no idea what's been said?
S

[bobalot] 15/3/2018 16:00

Based on late afternoon trades the Paris Big Pharma presentation has gone rather well...Cath was scheduled for about 2:30pm.

[rafboy] 15/3/2018 15:35

Shrewdmole, ooops.

[bobalot] 15/3/2018 15:31

Just got a reply from Shares Mag about when Human testing will start. They said the original article is now being corrected to show the correct schedule which is Q3 this year and it only lasts for a month.

[bobalot] 15/3/2018 15:21

One thing is for sure the company have a commercial partner for the cosmetic cream and Dr Cath is working very hard doing industry presentations to find more partners: Paris Pharma today and Amsterdam a week or two ago.

An interesting feature of the ingredient is the fact proved by Cardiff Uni is the microbe can be used to prevent skin cancer. Perhaps making it an ideal ingredient for suntan lotion.

[bobalot] 15/3/2018 15:14

The delay in the trials is all about which format should be adopted for each product, i.e. cream, gel or lotion. I am expecting the three products to use each of the three format offerrings to maximise market penetration in a range of market sectors.

In other words the company could end up with a wide range of applications when the patents are used as an ingredient....its worth billions imo.

About the much touted share divi...I don't expect it to be more than a ratio of 1:200 or 0.5-1% applied to LTH's with a lock in. But until the business make an announcement by way of an RNS such ramblings are based on supposition by some and guesswork by many.

[shrewdmole] 15/3/2018 14:19

A lot of people are talking about the free Sbtx shares to Opti holders having a negative impact here but I can't see Opti distributing until q3/q4 by which time we should be IMHO at a multiple of current price.

I also think it would be shrewd of Cath and very possible that a multi national could sign up early to fund the human trials a bit like Opti have commitment from partners so we could get commercial tie up prior to human trials.

Think about it why are the trials q3 when they've done the test scale up manufacture, they've tested on human skin in the lab and they've got to the ideal dosage?

Could be a lot more going on here than we are aware of.

I think it's an absolute bargain and also once Opti launches lpldl in uk and they start to motor naturally investors will look in here too.

Just my ramblings on a quiet day.

S

[shrewdmole] 15/3/2018 13:22

Raf

That's because the article is dated December 2017!

[bobalot] 15/3/2018 11:02

The Human Trials start this year in Q3 backed off from Q2 originally stated and that will be followed by commercialization with signed up partners.